Abstract 11621: Effect of Genotype Guided Oral P2y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Rahul Gupta,Aaqib H. Malik,Abhishek Chaturvedi,Sandipan Chakraborty,Pranav Mahajan,Sanjay Mehta,Wilbert S. Aronow,Apurva Vyas,Nainesh Patel,Hasan Ahmad

Abstract 11621: Effect of Genotype Guided Oral P2y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

2021

Rahul Gupta
Aaqib H. Malik
Abhishek Chaturvedi
Sandipan Chakraborty
Pranav Mahajan
Sanjay Mehta
Wilbert S. Aronow
Apurva Vyas
Nainesh Patel
Hasan Ahmad

Introduction: Clopidogrel is the most frequently used P2Y12 inhibitor as a component of the dual antiplatelet regimen in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary...

Keywords:

Percutaneous coronary intervention
Regimen
Clopidogrel
Acute coronary syndrome
Randomized controlled trial
Prasugrel
Ticagrelor
Internal medicine
P2Y12
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations